Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis

BACKGROUND: The Ranibizumab AMD Clinical Efficacy Study (RACER) conducted in treatment-naive adult Taiwanese patients with neovascular age-related macular degeneration (nAMD) suggested the importance of early and intensive dosing of ranibizumab for optimal treatment outcomes. This subgroup analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ching-Yao, Wu, Chien-Liang, Cheng, Cheng-Kuo, Shen, Yun-Dun, Wu, Wen-Chuan, Wu, Pei-Chang, Tsai, Arslan, Chen, Jiann-Torng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881324/
https://www.ncbi.nlm.nih.gov/pubmed/36707779
http://dx.doi.org/10.1186/s12886-023-02780-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881324/
https://www.ncbi.nlm.nih.gov/pubmed/36707779
http://dx.doi.org/10.1186/s12886-023-02780-0

Ejemplares similares